For the quarter ending 2026-03-31, BHC had -$13M decrease in cash & cash equivalents over the period. $121M in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -1,431 | -103 | 181 | 42 |
| Depreciation and amortization of intangible assets | 295 | 290 | 306 | 612 |
| Asset impairments | - | 7 | 1 | 0 |
| Amortization and write-off of debt premiums, discounts and issuance costs | 14 | 22 | 16 | 56 |
| Goodwill impairments | 1,426 | 145 | - | - |
| Acquisition-related contingent consideration | 12 | 36 | -32 | -40 |
| Allowances for losses on trade receivable and inventories | 26 | 23 | 12 | 36 |
| Deferred income taxes | 30 | 155 | -24 | -51 |
| Net gain on sale of assets | 3 | 0 | 6 | 0 |
| Adjustments to accrued legal settlements | -10 | -21 | -35 | -5 |
| Payments of accrued legal settlements | 161 | 17 | 92 | 106 |
| Share-based compensation | 52 | 84 | 43 | 89 |
| Gain excluded from hedge effectiveness | 3 | 2 | 2 | 6 |
| Loss on extinguishment of debt | -1 | -19 | 3 | 178 |
| Third party fees paid in connection with the 2022 exchange | - | 0 | - | - |
| Payments of contingent consideration adjustments, including accretion | 3 | 2 | 2 | 4 |
| Amortization of inventory step-up resulting from acquisitions | 3 | 2 | 20 | 42 |
| Foreign exchange and other | -5 | -7 | -5 | 23 |
| Trade receivables | -148 | -65 | 218 | -19 |
| Inventories | 14 | 5 | -16 | 23 |
| Prepaid expenses and other current assets | 27 | -32 | -5 | 34 |
| Accounts payable, accrued and other liabilities | -150 | -284 | 144 | 64 |
| Net cash provided by operating activities | 230 | 495 | 405 | 500 |
| Acquisitions and other investments | 0 | 187 | 5 | 12 |
| Purchases of property, plant and equipment | 109 | 92 | 91 | 214 |
| Acquisition of intangible assets and other assets | 38 | 0 | 0 | 10 |
| Purchases of marketable securities | 1 | 5 | 1 | 5 |
| Proceeds from sale of marketable securities | 1 | 2 | 1 | 5 |
| Proceeds from sale of assets and businesses, net of costs to sell | 3 | 0 | 7 | 0 |
| Interest settlements from cross-currency swaps | -5 | 0 | -6 | -6 |
| Net cash used in investing activities | -139 | -282 | -83 | -230 |
| Issuance of long-term debt, net of discounts | 2,802 | 133 | -1 | 10,422 |
| Repayments of long-term debt | 2,857 | 352 | 704 | 10,135 |
| Payments of employee withholding taxes related to share-based awards | 34 | 0 | 5 | 19 |
| Payments of acquisition-related contingent consideration | 8 | 8 | 6 | 12 |
| Payments of financing costs | 1 | 7 | 2 | 36 |
| Other | -2 | -1 | -1 | -8 |
| Net cash used in financing activities | -100 | -235 | -719 | 212 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -4 | 7 | -6 | 60 |
| Net decrease in cash, cash equivalents and restricted cash | -13 | -15 | -403 | 542 |
| Cash, cash equivalents and restricted cash, beginning of period | 1,340 | - | 1,201 | - |
| Cash, cash equivalents and restricted cash, end of period | 1,312 | - | 1,340 | - |
Bausch Health Companies Inc. (BHC)
Bausch Health Companies Inc. (BHC)